Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11588994rdf:typepubmed:Citationlld:pubmed
pubmed-article:11588994lifeskim:mentionsumls-concept:C0232338lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C1850451lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C0333562lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C0221099lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C0205182lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C1848924lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C1418854lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:11588994lifeskim:mentionsumls-concept:C0205248lld:lifeskim
pubmed-article:11588994pubmed:dateCreated2001-10-8lld:pubmed
pubmed-article:11588994pubmed:abstractTextA 5-year-old boy presented with frequent absences. Speech began to regress. He became ataxic, barely able to walk. Studies with Xe-133 and hexamethylpropylene amine oxime single-photon emission computed tomography revealed sharply decreased cerebral blood flow, especially in the occipital area. Landau-Kleffner syndrome was suspected but a sleep electroencephalogram showed few abnormalities. He was started on clorazepate and diltiazem. A skin biopsy to rule out possible CLN2 revealed, instead of the predicted curvilinear profiles, granular osmiophilic deposits, consistent with infantile neuronal ceroid lipofuscinosis (CLN1). The family reported increased seizure frequency and consulted with a colleague, who advised them to resume valproate and discontinue diltiazem. The boy died shortly thereafter. Decreased cerebral blood flow is a new finding in CLN1 with delayed onset. Calcium-channel blockers improve cerebral blood flow and perhaps delay clinical regression.lld:pubmed
pubmed-article:11588994pubmed:languageenglld:pubmed
pubmed-article:11588994pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11588994pubmed:citationSubsetIMlld:pubmed
pubmed-article:11588994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11588994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11588994pubmed:statusMEDLINElld:pubmed
pubmed-article:11588994pubmed:issn1090-3798lld:pubmed
pubmed-article:11588994pubmed:authorpubmed-author:PhilippartMMlld:pubmed
pubmed-article:11588994pubmed:authorpubmed-author:MenaIIlld:pubmed
pubmed-article:11588994pubmed:authorpubmed-author:PinedaGGlld:pubmed
pubmed-article:11588994pubmed:authorpubmed-author:WisniewskiK...lld:pubmed
pubmed-article:11588994pubmed:issnTypePrintlld:pubmed
pubmed-article:11588994pubmed:volume5 Suppl Alld:pubmed
pubmed-article:11588994pubmed:ownerNLMlld:pubmed
pubmed-article:11588994pubmed:authorsCompleteYlld:pubmed
pubmed-article:11588994pubmed:pagination185-7lld:pubmed
pubmed-article:11588994pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:meshHeadingpubmed-meshheading:11588994...lld:pubmed
pubmed-article:11588994pubmed:year2001lld:pubmed
pubmed-article:11588994pubmed:articleTitleImpaired temporo-occipital blood flow in an atypical CLN1 case with late infantile onset and granular osmiophilic deposits.lld:pubmed
pubmed-article:11588994pubmed:affiliationMental Retardation Center, UCLA School of Medicine, Los Angeles, California, USA. mphilipp@ucla.edulld:pubmed
pubmed-article:11588994pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11588994pubmed:publicationTypeCase Reportslld:pubmed